Literature DB >> 15613702

Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?

Glen L Hortin.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15613702     DOI： 10.1373/clinchem.2004.043281

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  20 in total

1.  Diverse range of small peptides associated with high-density lipoprotein.

Authors:  Glen L Hortin; Rong-Fong Shen; Brian M Martin; Alan T Remaley
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

Review 2.  Multiplexed protein measurement: technologies and applications of protein and antibody arrays.

Authors:  Stephen F Kingsmore
Journal:  Nat Rev Drug Discov       Date:  2006-04       Impact factor: 84.694

3.  Assessing the social meaning, value and implications of research in genomics.

Authors:  Blanca Lumbreras; Miquel Porta; Ildefonso Hernández-Aguado
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

4.  Bringing diagnostic technologies to the clinical laboratory: Rigor, regulation, and reality.

Authors:  Gordon Whiteley
Journal:  Proteomics Clin Appl       Date:  2008       Impact factor: 3.494

Review 5.  Application of proteomic analysis to the study of renal diseases.

Authors:  Matthew P Welberry Smith; Rosamonde E Banks; Steven L Wood; Andrew J P Lewington; Peter J Selby
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

Review 6.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

7.  Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.

Authors:  James R Hocker; Russell G Postier; Min Li; Megan R Lerner; Stan A Lightfoot; Marvin D Peyton; Subrato J Deb; Candace M Baker; Travis L Williams; Rushie Jane Hanas; Donald E Stowell; Theresa J Lander; Daniel J Brackett; Jay S Hanas
Journal:  Cancer Lett       Date:  2015-01-28       Impact factor: 8.679

8.  A gel-free approach in vascular smooth muscle cell proteome: perspectives for a better insight into activation.

Authors:  Silvia Rocchiccioli; Lorenzo Citti; Claudia Boccardi; Nadia Ucciferri; Lorena Tedeschi; Caterina Lande; Maria Giovanna Trivella; Antonella Cecchettini
Journal:  Proteome Sci       Date:  2010-03-24       Impact factor: 2.480

9.  Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation.

Authors:  James R Hocker; Altaf Mohammed; Christopher E Aston; Misty Brewer; Stan A Lightfoot; Chinthalapally V Rao; Jay S Hanas
Journal:  Int J Cancer       Date:  2013-07-01       Impact factor: 7.396

Review 10.  Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics.

Authors:  David E Amacher; Shelli J Schomaker; Jiri Aubrecht
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.